MOCS1

Chr 6AR

molybdenum cofactor synthesis 1

Also known as: MIG11, MOCOD, MOCS1A, MOCS1B

The protein catalyzes the conversion of GTP to cyclic pyranopterin monophosphate, the first step in molybdenum cofactor biosynthesis, with isoform MOCS1A performing GTP cyclization and isoform MOCS1B converting the intermediate to cyclic pyranopterin monophosphate. Biallelic mutations cause molybdenum cofactor deficiency type A, inherited in an autosomal recessive pattern. Loss-of-function mutations disrupt this essential cofactor synthesis pathway required for multiple molybdenum-dependent enzymes.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismARLOEUF 1.081 OMIM phenotype
Clinical SummaryMOCS1
🧬
Gene-Disease Validity (ClinGen)
sulfite oxidase deficiency due to molybdenum cofactor deficiency type A · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 125 VUS of 300 total submissions
📖
GeneReview available — MOCS1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.08LOEUF
pLI 0.000
Z-score 1.30
OE 0.67 (0.431.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.62Z-score
OE missense 1.12 (1.011.24)
257 obs / 230.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.67 (0.431.08)
00.351.4
Missense OE1.12 (1.011.24)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 12 / 18.0Missense obs/exp: 257 / 230.5Syn Z: -0.13
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMOCS1-related molybdenum cofactor deficiencyLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7132th %ile
GOF
0.5170th %ile
LOF
0.4038th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

300 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic20
VUS125
Likely Benign118
Benign1
Conflicting2
25
Pathogenic
20
Likely Pathogenic
125
VUS
118
Likely Benign
1
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
23
0
2
0
25
Likely Pathogenic
19
1
0
0
20
VUS
5
97
13
10
125
Likely Benign
0
1
36
81
118
Benign
0
0
1
0
1
Conflicting
2
Total47995291291

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MOCS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →